Rapid tests for Trichomonas vaginalis antigens

Summary

The procurement covers an estimated 1,200 rapid immunochromatographic tests for the qualitative detection of Trichomonas vaginalis antigens over a 36-month contract. The device must carry a CE mark for in vitro diagnostic use and be validated for vaginal swab samples. The quantity is an estimate, and the buyer is not required to order it all. The total contract price must not exceed EUR 10,224 excluding VAT, and prices remain fixed for the contract term. Bidders must provide the device’s INFARMED registration or assigned medical device code, confirmation that INFARMED registration and commercialisation fees are up to date, and the product’s technical documentation. Delivery must take no more than 5 days from receipt of an order. Price accounts for 60% and quality for 40% of the award score. Quality scoring considers documented validation for cervical exudate, ureteral exudate and urine samples, and use in males. The submission deadline is 11 October 2026 at 17:00, and bids must remain valid for 120 days. Variants are not permitted.